Development of anti-filovirus polyclonal antibodies
$560,197Y01FY2018AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
To support the development and production of anti-filovirus polyclonal antibodies in support of Ebola virus vaccine development
View original record on NIH RePORTER →